Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment

We report an 82-year-old lady who developed sudden onset nodular and erythematous lesions and neutrophilia following an episode of urinary tract infection. Skin biopsy confirmed the diagnosis of Sweet syndrome. Response to the use of prednisolone alone was not satisfactory. The skin lesions however...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Harry H. S., Leung, Anskar Y. H., Trendell-Smith, N. J., Yeung, C. K., Liang, Raymond
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847699/
https://www.ncbi.nlm.nih.gov/pubmed/20369066
http://dx.doi.org/10.1155/2010/328316
_version_ 1782179588943642624
author Gill, Harry H. S.
Leung, Anskar Y. H.
Trendell-Smith, N. J.
Yeung, C. K.
Liang, Raymond
author_facet Gill, Harry H. S.
Leung, Anskar Y. H.
Trendell-Smith, N. J.
Yeung, C. K.
Liang, Raymond
author_sort Gill, Harry H. S.
collection PubMed
description We report an 82-year-old lady who developed sudden onset nodular and erythematous lesions and neutrophilia following an episode of urinary tract infection. Skin biopsy confirmed the diagnosis of Sweet syndrome. Response to the use of prednisolone alone was not satisfactory. The skin lesions however showed a sustained response to the regular use of intravenous immunoglobulin (IVIG) and prednisolone was slowly weaned off. Our case highlights the possible therapeutic role of IVIG in managing this condition.
format Text
id pubmed-2847699
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28476992010-04-05 Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment Gill, Harry H. S. Leung, Anskar Y. H. Trendell-Smith, N. J. Yeung, C. K. Liang, Raymond Adv Hematol Case Report We report an 82-year-old lady who developed sudden onset nodular and erythematous lesions and neutrophilia following an episode of urinary tract infection. Skin biopsy confirmed the diagnosis of Sweet syndrome. Response to the use of prednisolone alone was not satisfactory. The skin lesions however showed a sustained response to the regular use of intravenous immunoglobulin (IVIG) and prednisolone was slowly weaned off. Our case highlights the possible therapeutic role of IVIG in managing this condition. Hindawi Publishing Corporation 2010 2010-03-29 /pmc/articles/PMC2847699/ /pubmed/20369066 http://dx.doi.org/10.1155/2010/328316 Text en Copyright © 2010 Harry H. S. Gill et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gill, Harry H. S.
Leung, Anskar Y. H.
Trendell-Smith, N. J.
Yeung, C. K.
Liang, Raymond
Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
title Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
title_full Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
title_fullStr Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
title_full_unstemmed Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
title_short Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
title_sort sweet syndrome due to myelodysplastic syndrome: possible therapeutic role of intravenous immunoglobulin in addition to standard treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847699/
https://www.ncbi.nlm.nih.gov/pubmed/20369066
http://dx.doi.org/10.1155/2010/328316
work_keys_str_mv AT gillharryhs sweetsyndromeduetomyelodysplasticsyndromepossibletherapeuticroleofintravenousimmunoglobulininadditiontostandardtreatment
AT leunganskaryh sweetsyndromeduetomyelodysplasticsyndromepossibletherapeuticroleofintravenousimmunoglobulininadditiontostandardtreatment
AT trendellsmithnj sweetsyndromeduetomyelodysplasticsyndromepossibletherapeuticroleofintravenousimmunoglobulininadditiontostandardtreatment
AT yeungck sweetsyndromeduetomyelodysplasticsyndromepossibletherapeuticroleofintravenousimmunoglobulininadditiontostandardtreatment
AT liangraymond sweetsyndromeduetomyelodysplasticsyndromepossibletherapeuticroleofintravenousimmunoglobulininadditiontostandardtreatment

Ejemplares similares